We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+4.45%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$9.86B
AUM Growth
-$168M
Cap. Flow
-$326M
Cap. Flow %
-3.31%
Top 10 Hldgs %
9.48%
Holding
825
New
63
Increased
274
Reduced
363
Closed
64

Top Buys

Rank Stock Value
1
JJSF icon
J&J Snack Foods
JJSF
+$29.7M
2
WDFC icon
WD-40
WDFC
+$28.7M
3
CBZ icon
CBIZ
CBZ
+$27.6M
4
EXPO icon
Exponent
EXPO
+$19.4M
5
ANDG
Andersen Group
ANDG
+$19.3M

Sector Composition

Rank Sector Weight
1 Industrials 25.96%
2 Technology 18.79%
3 Financials 16.43%
4 Consumer Discretionary 12.93%
5 Healthcare 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBCF icon
76
Seacoast Banking Corp of Florida
SBCF
$3.34B
$31.8M 0.32%
1,011,225
-231,060
-19% -$7.2M
NWPX icon
77
NWPX Infrastructure Inc
NWPX
$1.08B
$31.7M 0.32%
507,306
-29,882
-6% -$1.72M
BBSI icon
78
Barrett Business Services
BBSI
$836M
$31.5M 0.32%
870,863
+208,865
+32% +$7.99M
AMRC icon
79
Ameresco
AMRC
$1.17B
$31.2M 0.32%
1,066,792
+102,782
+11% +$3.61M
CMC icon
80
Commercial Metals
CMC
$7.52B
$31.1M 0.32%
449,932
-41,860
-9% -$2.62M
NOMD icon
81
Nomad Foods
NOMD
$1.68B
$31.1M 0.32%
2,484,858
+33,052
+1% +$404K
MORN icon
82
Morningstar
MORN
$8.18B
$31.1M 0.32%
143,011
+3,635
+3% +$787K
LNN icon
83
Lindsay Corp
LNN
$1.16B
$30.8M 0.31%
261,527
-36,343
-12% -$4.37M
NSP icon
84
Insperity
NSP
$2.06B
$30.7M 0.31%
792,834
+265,041
+50% +$10.6M
SLGN icon
85
Silgan Holdings
SLGN
$4.45B
$30.5M 0.31%
755,611
+46,706
+7% +$1.9M
HIFS icon
86
Hingham Institution for Saving
HIFS
$656M
$30.4M 0.31%
107,030
-5,743
-5% -$1.64M
GHM icon
87
Graham Corp
GHM
$1.03B
$30.3M 0.31%
472,207
+12,509
+3% +$755K
JJSF icon
88
J&J Snack Foods
JJSF
$1.67B
$29.6M 0.3%
+327,501
New +$29.7M
TMDX icon
89
Transmedics
TMDX
$3.1B
$29.6M 0.3%
243,149
PI icon
90
Impinj
PI
$5.19B
$29.2M 0.3%
167,882
-1,917
-1% -$342K
PACS icon
91
PACS Group
PACS
$6.86B
$28.6M 0.29%
746,234
-1,112,836
-60% -$24.4M
ATRO icon
92
Astronics
ATRO
$3.28B
$28.2M 0.29%
624,716
-101,016
-14% -$4.24M
VC icon
93
Visteon
VC
$2.73B
$28.1M 0.29%
295,611
+30,897
+12% +$3.27M
HOMB icon
94
Home BancShares
HOMB
$5.94B
$28M 0.28%
1,008,765
-104,753
-9% -$2.91M
TKR icon
95
Timken Company
TKR
$8.43B
$27.8M 0.28%
331,004
-61,633
-16% -$4.9M
UCTT
96
Ultra Clean Holdings
UCTT
$3.21B
$27.8M 0.28%
1,098,693
-8,723
-0.8% -$232K
APG icon
97
APi Group
APG
$17.2B
$27.8M 0.28%
726,829
TGNA
98
DELISTED
TEGNA Inc
TGNA
$27.8M 0.28%
1,432,316
+7,731
+0.5% +$153K
DFIN icon
99
Donnelley Financial Solutions
DFIN
$1.19B
$27.6M 0.28%
590,136
+156,059
+36% +$7.55M
MBIN icon
100
Merchants Bancorp
MBIN
$2.46B
$27.5M 0.28%
808,314
-53,805
-6% -$1.77M

Similar funds

Royce & Associates's Q4 2025 Portfolio in Review

As of Q4 2025, Royce & Associates held 825 positions worth $9.86B, down 1.7% from $10B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Royce & Associates withdrew a net $326M in Q4 2025, closing 64 positions and reducing 363 holdings. Its most notable exit was Charles River Laboratories, an estimated $13.2M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 26% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in J&J Snack Foods worth $29.6M.

  • Royce & Associates's largest Q4 2025 buy was J&J Snack Foods: 327,501 shares worth $29.6M.
  • Royce & Associates added most to WD-40 in Q4 2025, an estimated $28.7M increase.
  • Royce & Associates's biggest Q4 2025 reduction was Haemonetics, cutting an estimated $42.3M.
  • Royce & Associates fully exited Charles River Laboratories in Q4 2025, selling an estimated $13.2M.
  • Royce & Associates's ten largest holdings make up 9.5% of its $9.86B portfolio in Q4 2025.
  • Royce & Associates opened 63 new positions and closed 64 in Q4 2025.
  • Royce & Associates's portfolio value fell 1.7% quarter-over-quarter to $9.86B.

Based on Royce & Associates's 13F filing for Q4 2025, filed 9 Feb 2026.